JP Morgan Chase
HIMS icon

JP Morgan Chase’s Hims & Hers Health HIMS Stock Holding History

JP Morgan Chase’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159M Sell
4,766,781
-474,035
-9% -$12.7M 0.01% 841
2026
Q1 		$98.4M Sell
5,240,816
-13,597,454
-72% -$321M 0.01% 992
2025
Q4 		$612M Buy
18,838,270
+1,052,185
+6% +$45.1M 0.04% 361
2025
Q3 		$1.01B Buy
17,786,085
+15,045,710
+549% +$771M 0.06% 280
2025
Q2 		$137M Buy
2,740,375
+111,595
+4% +$5.04M 0.01% 811
2025
Q1 		$77.7M Sell
2,628,780
-81,234
-3% -$3.02M 0.01% 1070
2024
Q4 		$65.5M Buy
2,710,014
+659,892
+32% +$16.3M ﹤0.01% 1154
2024
Q3 		$37.8M Sell
2,050,122
-504,044
-20% -$9.02M ﹤0.01% 1510
2024
Q2 		$51.6M Buy
2,554,166
+2,237,915
+708% +$37.2M ﹤0.01% 1231
2024
Q1 		$4.89M Buy
316,251
+149,251
+89% +$1.68M ﹤0.01% 3124
2023
Q4 		$1.49M Buy
167,000
+450
+0.3% +$3.33K ﹤0.01% 4060
2023
Q3 		$1.05M Sell
166,550
-11,133
-6% -$82.8K ﹤0.01% 4036
2023
Q2 		$1.67M Sell
177,683
-174,032
-49% -$1.73M ﹤0.01% 3675
2023
Q1 		$3.49M Buy
351,715
+226,226
+180% +$1.98M ﹤0.01% 3100
2022
Q4 		$804K Buy
125,489
+13,276
+12% +$75.6K ﹤0.01% 4206
2022
Q3 		$626K Sell
112,213
-351
-0.3% -$2.12K ﹤0.01% 4312
2022
Q2 		$510K Buy
112,564
+77,231
+219% +$329K ﹤0.01% 4533
2022
Q1 		$188K Sell
35,333
-58,607
-62% -$290K ﹤0.01% 5226
2021
Q4 		$614K Sell
93,940
-3,486
-4% -$25.2K ﹤0.01% 4700
2021
Q3 		$735K Buy
97,426
+81,986
+531% +$694K ﹤0.01% 4508
2021
Q2 		$168K Buy
+15,440
New +$184K ﹤0.01% 5325
2020
Q4 		– Sell
-204,471
Closed -$2.37M – 5745
2020
Q3 		$2.37M Buy
+204,471
New +$2.18M ﹤0.01% 3127

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

JP Morgan Chase's HIMS Position: Q2 2026 in Review

JP Morgan Chase reduced its Hims & Hers Health (HIMS) stake by 9% in Q2 2026, selling an estimated $12.7M and leaving 4,766,781 shares worth $159M. The position accounts for 0.01% of the portfolio, ranked #841.

JP Morgan Chase first reported a position in HIMS in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.01B in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • JP Morgan Chase held 4,766,781 shares of Hims & Hers Health worth $159M as of Q2 2026.
  • JP Morgan Chase sold 474,035 Hims & Hers Health shares in Q2 2026, an estimated $12.7M.
  • Hims & Hers Health made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #841 holding.
  • JP Morgan Chase first reported a position in Hims & Hers Health in Q3 2020 and has held it in 22 quarters since.
  • JP Morgan Chase's Hims & Hers Health position peaked at $1.01B in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.